食道がん治療薬の世界市場 2019年版：種類別（フルオロウラシル、シスプラチン、ドセタキセル、カルボプラチン、その他）、用途別（標的療法、化学療法）

• 英文タイトル：Global Esophageal Cancer Drugs Market 2019 by Company, Regions, Type and Application, Forecast to 2024

• レポートコード：C-GIR20G2704 • 出版社/出版日：GlobalInfoResearch / 2019年12月30日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、102ページ • 納品方法：Eメール • 産業分類：医薬品・医療

• 販売価格（消費税別）

Single User	￥515,040 (USD3,480)	▷ お問い合わせ
Multi User	￥772,560 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,030,080 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

「食道がん治療薬の世界市場2019年」は、グローバルにおける食道がん治療薬市場を展望するレポートです。食道がん治療薬のグローバル市場概観、企業動向、企業別シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどを掲載しています。 ・食道がん治療薬の市場概観 ・食道がん治療薬の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・食道がん治療薬の企業別販売動向、市場シェア、市場集中度、競争動向 ・食道がん治療薬の世界市場規模 ・食道がん治療薬の北米市場分析（アメリカ、カナダ、メキシコ等） ・食道がん治療薬のアメリカ市場規模推移 ・食道がん治療薬のカナダ市場規模推移 ・食道がん治療薬のメキシコ市場規模推移 ・食道がん治療薬のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・食道がん治療薬のドイツ市場規模推移 ・食道がん治療薬のイギリス市場規模推移 ・食道がん治療薬のロシア市場規模推移 ・食道がん治療薬のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・食道がん治療薬の日本市場規模推移 ・食道がん治療薬の中国市場規模推移 ・食道がん治療薬の韓国市場規模推移 ・食道がん治療薬のインド市場規模推移 ・食道がん治療薬の東南アジア市場規模推移 ・食道がん治療薬の南米市場分析（ブラジル、アルゼンチン等） ・食道がん治療薬の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・食道がん治療薬の種類別分析/販売量、売上、市場シェア（フルオロウラシル、シスプラチン、ドセタキセル、カルボプラチン、その他） ・食道がん治療薬の用途別分析/市場規模（標的療法、化学療法） ・食道がん治療薬の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・食道がん治療薬の販売チャネル・代理店・貿易業者・ディーラー分析

Scope of the Report:
The global Esophageal Cancer Drugs market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Esophageal Cancer Drugs.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Esophageal Cancer Drugs market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Esophageal Cancer Drugs market by product type and applications/end industries.

Market Segment by Companies, this report covers
Bristol-Myers Squibb Company
Merck & Co., Inc.
Eli Lilly and Company
F. Hoffmann-La Roche Ltd
Sanofi

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Fluorouracil
Cisplatin
Docetaxel
Carboplatin
Others

Market Segment by Applications, can be divided into
Targeted Therapy
Chemotherapy

レポート目次

---

Table of Contents

1 Esophageal Cancer Drugs Market Overview
1.1 Product Overview and Scope of Esophageal Cancer Drugs
1.2 Classification of Esophageal Cancer Drugs by Types
1.2.1 Global Esophageal Cancer Drugs Revenue Comparison by Types (2019-2024)
1.2.2 Global Esophageal Cancer Drugs Revenue Market Share by Types in 2018
1.2.3 Fluorouracil
1.2.4 Cisplatin
1.2.5 Docetaxel
1.2.6 Carboplatin
1.2.7 Others
1.3 Global Esophageal Cancer Drugs Market by Application
1.3.1 Global Esophageal Cancer Drugs Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Targeted Therapy
1.3.3 Chemotherapy
1.4 Global Esophageal Cancer Drugs Market by Regions
1.4.1 Global Esophageal Cancer Drugs Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Esophageal Cancer Drugs Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Esophageal Cancer Drugs Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Esophageal Cancer Drugs Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Esophageal Cancer Drugs Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Esophageal Cancer Drugs Status and Prospect (2014-2024)
1.5 Global Market Size of Esophageal Cancer Drugs (2014-2024)
2 Company Profiles
2.1 Bristol-Myers Squibb Company
2.1.1 Business Overview
2.1.2 Esophageal Cancer Drugs Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Bristol-Myers Squibb Company Esophageal Cancer Drugs Revenue, Gross Margin and Market Share (2017-2018)
2.2 Merck & Co., Inc.
2.2.1 Business Overview
2.2.2 Esophageal Cancer Drugs Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Merck & Co., Inc. Esophageal Cancer Drugs Revenue, Gross Margin and Market Share (2017-2018)
2.3 Eli Lilly and Company
2.3.1 Business Overview
2.3.2 Esophageal Cancer Drugs Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Eli Lilly and Company Esophageal Cancer Drugs Revenue, Gross Margin and Market Share (2017-2018)
2.4 F. Hoffmann-La Roche Ltd
2.4.1 Business Overview
2.4.2 Esophageal Cancer Drugs Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 F. Hoffmann-La Roche Ltd Esophageal Cancer Drugs Revenue, Gross Margin and Market Share (2017-2018)
2.5 Sanofi
2.5.1 Business Overview
2.5.2 Esophageal Cancer Drugs Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Sanofi Esophageal Cancer Drugs Revenue, Gross Margin and Market Share (2017-2018)
3 Global Esophageal Cancer Drugs Market Competition, by Players
3.1 Global Esophageal Cancer Drugs Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Esophageal Cancer Drugs Players Market Share
3.2.2 Top 10 Esophageal Cancer Drugs Players Market Share
3.3 Market Competition Trend
4 Global Esophageal Cancer Drugs Market Size by Regions
4.1 Global Esophageal Cancer Drugs Revenue and Market Share by Regions
4.2 North America Esophageal Cancer Drugs Revenue and Growth Rate (2014-2019)
4.3 Europe Esophageal Cancer Drugs Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Esophageal Cancer Drugs Revenue and Growth Rate (2014-2019)
4.5 South America Esophageal Cancer Drugs Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Esophageal Cancer Drugs Revenue and Growth Rate (2014-2019)
5 North America Esophageal Cancer Drugs Revenue by Countries
5.1 North America Esophageal Cancer Drugs Revenue by Countries (2014-2019)
5.2 USA Esophageal Cancer Drugs Revenue and Growth Rate (2014-2019)
5.3 Canada Esophageal Cancer Drugs Revenue and Growth Rate (2014-2019)
5.4 Mexico Esophageal Cancer Drugs Revenue and Growth Rate (2014-2019)
6 Europe Esophageal Cancer Drugs Revenue by Countries
6.1 Europe Esophageal Cancer Drugs Revenue by Countries (2014-2019)
6.2 Germany Esophageal Cancer Drugs Revenue and Growth Rate (2014-2019)
6.3 UK Esophageal Cancer Drugs Revenue and Growth Rate (2014-2019)
6.4 France Esophageal Cancer Drugs Revenue and Growth Rate (2014-2019)
6.5 Russia Esophageal Cancer Drugs Revenue and Growth Rate (2014-2019)
6.6 Italy Esophageal Cancer Drugs Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Esophageal Cancer Drugs Revenue by Countries
7.1 Asia-Pacific Esophageal Cancer Drugs Revenue by Countries (2014-2019)
7.2 China Esophageal Cancer Drugs Revenue and Growth Rate (2014-2019)
7.3 Japan Esophageal Cancer Drugs Revenue and Growth Rate (2014-2019)
7.4 Korea Esophageal Cancer Drugs Revenue and Growth Rate (2014-2019)
7.5 India Esophageal Cancer Drugs Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Esophageal Cancer Drugs Revenue and Growth Rate (2014-2019)
8 South America Esophageal Cancer Drugs Revenue by Countries
8.1 South America Esophageal Cancer Drugs Revenue by Countries (2014-2019)
8.2 Brazil Esophageal Cancer Drugs Revenue and Growth Rate (2014-2019)
8.3 Argentina Esophageal Cancer Drugs Revenue and Growth Rate (2014-2019)
8.4 Colombia Esophageal Cancer Drugs Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Esophageal Cancer Drugs by Countries
9.1 Middle East and Africa Esophageal Cancer Drugs Revenue by Countries (2014-2019)
9.2 Saudi Arabia Esophageal Cancer Drugs Revenue and Growth Rate (2014-2019)
9.3 UAE Esophageal Cancer Drugs Revenue and Growth Rate (2014-2019)
9.4 Egypt Esophageal Cancer Drugs Revenue and Growth Rate (2014-2019)
9.5 Nigeria Esophageal Cancer Drugs Revenue and Growth Rate (2014-2019)
9.6 South Africa Esophageal Cancer Drugs Revenue and Growth Rate (2014-2019)
10 Global Esophageal Cancer Drugs Market Segment by Type
10.1 Global Esophageal Cancer Drugs Revenue and Market Share by Type (2014-2019)
10.2 Global Esophageal Cancer Drugs Market Forecast by Type (2019-2024)
10.3 Fluorouracil Revenue Growth Rate (2014-2024)
10.4 Cisplatin Revenue Growth Rate (2014-2024)
10.5 Docetaxel Revenue Growth Rate (2014-2024)
10.6 Carboplatin Revenue Growth Rate (2014-2024)
10.7 Others Revenue Growth Rate (2014-2024)
11 Global Esophageal Cancer Drugs Market Segment by Application
11.1 Global Esophageal Cancer Drugs Revenue Market Share by Application (2014-2019)
11.2 Esophageal Cancer Drugs Market Forecast by Application (2019-2024)
11.3 Targeted Therapy Revenue Growth (2014-2019)
11.4 Chemotherapy Revenue Growth (2014-2019)
12 Global Esophageal Cancer Drugs Market Size Forecast (2019-2024)
12.1 Global Esophageal Cancer Drugs Market Size Forecast (2019-2024)
12.2 Global Esophageal Cancer Drugs Market Forecast by Regions (2019-2024)
12.3 North America Esophageal Cancer Drugs Revenue Market Forecast (2019-2024)
12.4 Europe Esophageal Cancer Drugs Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Esophageal Cancer Drugs Revenue Market Forecast (2019-2024)
12.6 South America Esophageal Cancer Drugs Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Esophageal Cancer Drugs Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source

List of Tables and Figures

Figure Esophageal Cancer Drugs Picture
Table Product Specifications of Esophageal Cancer Drugs
Table Global Esophageal Cancer Drugs and Revenue (Million USD) Market Split by Product Type
Figure Global Esophageal Cancer Drugs Revenue Market Share by Types in 2018
Figure Fluorouracil Picture
Figure Cisplatin Picture
Figure Docetaxel Picture
Figure Carboplatin Picture
Figure Others Picture
Table Global Esophageal Cancer Drugs Revenue (Million USD) by Application (2014-2024)
Figure Esophageal Cancer Drugs Revenue Market Share by Applications in 2018
Figure Targeted Therapy Picture
Figure Chemotherapy Picture
Table Global Market Esophageal Cancer Drugs Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Esophageal Cancer Drugs Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Esophageal Cancer Drugs Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Esophageal Cancer Drugs Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Esophageal Cancer Drugs Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Esophageal Cancer Drugs Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Esophageal Cancer Drugs Revenue (Million USD) and Growth Rate (2014-2024)
Table Bristol-Myers Squibb Company Basic Information, Manufacturing Base and Competitors
Table Bristol-Myers Squibb Company Esophageal Cancer Drugs Type and Applications
Table Bristol-Myers Squibb Company Esophageal Cancer Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table Merck & Co., Inc. Basic Information, Manufacturing Base and Competitors
Table Merck & Co., Inc. Esophageal Cancer Drugs Type and Applications
Table Merck & Co., Inc. Esophageal Cancer Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table Eli Lilly and Company Basic Information, Manufacturing Base and Competitors
Table Eli Lilly and Company Esophageal Cancer Drugs Type and Applications
Table Eli Lilly and Company Esophageal Cancer Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table F. Hoffmann-La Roche Ltd Basic Information, Manufacturing Base and Competitors
Table F. Hoffmann-La Roche Ltd Esophageal Cancer Drugs Type and Applications
Table F. Hoffmann-La Roche Ltd Esophageal Cancer Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table Sanofi Basic Information, Manufacturing Base and Competitors
Table Sanofi Esophageal Cancer Drugs Type and Applications
Table Sanofi Esophageal Cancer Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table Global Esophageal Cancer Drugs Revenue (Million USD) by Players (2014-2019)
Table Global Esophageal Cancer Drugs Revenue Share by Players (2014-2019)
Figure Global Esophageal Cancer Drugs Revenue Share by Players in 2017
Figure Global Esophageal Cancer Drugs Revenue Share by Players in 2018
Figure Global Top 5 Players Esophageal Cancer Drugs Revenue Market Share in 2018
Figure Global Top 10 Players Esophageal Cancer Drugs Revenue Market Share in 2018
Figure Global Esophageal Cancer Drugs Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Esophageal Cancer Drugs Revenue (Million USD) by Regions (2014-2019)
Table Global Esophageal Cancer Drugs Revenue Market Share by Regions (2014-2019)
Figure Global Esophageal Cancer Drugs Revenue Market Share by Regions (2014-2019)
Figure Global Esophageal Cancer Drugs Revenue Market Share by Regions in 2018
Figure North America Esophageal Cancer Drugs Revenue and Growth Rate (2014-2019)
Figure Europe Esophageal Cancer Drugs Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Esophageal Cancer Drugs Revenue and Growth Rate (2014-2019)
Figure South America Esophageal Cancer Drugs Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Esophageal Cancer Drugs Revenue and Growth Rate (2014-2019)
Table North America Esophageal Cancer Drugs Revenue by Countries (2014-2019)
Table North America Esophageal Cancer Drugs Revenue Market Share by Countries (2014-2019)
Figure North America Esophageal Cancer Drugs Revenue Market Share by Countries (2014-2019)
Figure North America Esophageal Cancer Drugs Revenue Market Share by Countries in 2018
Figure USA Esophageal Cancer Drugs Revenue and Growth Rate (2014-2019)
Figure Canada Esophageal Cancer Drugs Revenue and Growth Rate (2014-2019)
Figure Mexico Esophageal Cancer Drugs Revenue and Growth Rate (2014-2019)
Table Europe Esophageal Cancer Drugs Revenue (Million USD) by Countries (2014-2019)
Figure Europe Esophageal Cancer Drugs Revenue Market Share by Countries (2014-2019)
Figure Europe Esophageal Cancer Drugs Revenue Market Share by Countries in 2018
Figure Germany Esophageal Cancer Drugs Revenue and Growth Rate (2014-2019)
Figure UK Esophageal Cancer Drugs Revenue and Growth Rate (2014-2019)
Figure France Esophageal Cancer Drugs Revenue and Growth Rate (2014-2019)
Figure Russia Esophageal Cancer Drugs Revenue and Growth Rate (2014-2019)
Figure Italy Esophageal Cancer Drugs Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Esophageal Cancer Drugs Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Esophageal Cancer Drugs Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Esophageal Cancer Drugs Revenue Market Share by Countries in 2018
Figure China Esophageal Cancer Drugs Revenue and Growth Rate (2014-2019)
Figure Japan Esophageal Cancer Drugs Revenue and Growth Rate (2014-2019)
Figure Korea Esophageal Cancer Drugs Revenue and Growth Rate (2014-2019)
Figure India Esophageal Cancer Drugs Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Esophageal Cancer Drugs Revenue and Growth Rate (2014-2019)
Table South America Esophageal Cancer Drugs Revenue by Countries (2014-2019)
Table South America Esophageal Cancer Drugs Revenue Market Share by Countries (2014-2019)
Figure South America Esophageal Cancer Drugs Revenue Market Share by Countries (2014-2019)
Figure South America Esophageal Cancer Drugs Revenue Market Share by Countries in 2018
Figure Brazil Esophageal Cancer Drugs Revenue and Growth Rate (2014-2019)
Figure Argentina Esophageal Cancer Drugs Revenue and Growth Rate (2014-2019)
Figure Colombia Esophageal Cancer Drugs Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Esophageal Cancer Drugs Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Esophageal Cancer Drugs Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Esophageal Cancer Drugs Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Esophageal Cancer Drugs Revenue Market Share by Countries in 2018
Figure Saudi Arabia Esophageal Cancer Drugs Revenue and Growth Rate (2014-2019)
Figure UAE Esophageal Cancer Drugs Revenue and Growth Rate (2014-2019)
Figure Egypt Esophageal Cancer Drugs Revenue and Growth Rate (2014-2019)
Figure Nigeria Esophageal Cancer Drugs Revenue and Growth Rate (2014-2019)
Figure South Africa Esophageal Cancer Drugs Revenue and Growth Rate (2014-2019)
Table Global Esophageal Cancer Drugs Revenue (Million USD) by Type (2014-2019)
Table Global Esophageal Cancer Drugs Revenue Share by Type (2014-2019)
Figure Global Esophageal Cancer Drugs Revenue Share by Type (2014-2019)
Figure Global Esophageal Cancer Drugs Revenue Share by Type in 2018
Table Global Esophageal Cancer Drugs Revenue Forecast by Type (2019-2024)
Figure Global Esophageal Cancer Drugs Market Share Forecast by Type (2019-2024)
Figure Global Fluorouracil Revenue Growth Rate (2014-2019)
Figure Global Cisplatin Revenue Growth Rate (2014-2019)
Figure Global Docetaxel Revenue Growth Rate (2014-2019)
Figure Global Carboplatin Revenue Growth Rate (2014-2019)
Figure Global Others Revenue Growth Rate (2014-2019)
Table Global Esophageal Cancer Drugs Revenue by Application (2014-2019)
Table Global Esophageal Cancer Drugs Revenue Share by Application (2014-2019)
Figure Global Esophageal Cancer Drugs Revenue Share by Application (2014-2019)
Figure Global Esophageal Cancer Drugs Revenue Share by Application in 2018
Table Global Esophageal Cancer Drugs Revenue Forecast by Application (2019-2024)
Figure Global Esophageal Cancer Drugs Market Share Forecast by Application (2019-2024)
Figure Global Targeted Therapy Revenue Growth Rate (2014-2019)
Figure Global Chemotherapy Revenue Growth Rate (2014-2019)
Figure Global Esophageal Cancer Drugs Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Esophageal Cancer Drugs Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Esophageal Cancer Drugs Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Esophageal Cancer Drugs Revenue Market Forecast (2019-2024)
Figure Europe Esophageal Cancer Drugs Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Esophageal Cancer Drugs Revenue Market Forecast (2019-2024)
Figure South America Esophageal Cancer Drugs Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Esophageal Cancer Drugs Revenue Market Forecast (2019-2024)

---